Skip to main content
. 2020 Oct 2;11:555047. doi: 10.3389/fphar.2020.555047

Table 1.

Effect of eslicarbazepine acetate (300 μM) on Na+ current characteristics in MDA-MB-231 and HEK-Nav1.5 cells.1

A. MDA-MB-231 cells
Parameter Control ESL P value N
Vthres (mV) -45.7 ± 1.7 -45.0 ± 1.4 0.58 13
Vpeak (mV) 3.1 ± 2.1 -3.9 ± 2.7 0.056 13
Activation V½ (mV) -19.3 ± 1.4 -22.0 ± 1.5 0.095 12
Activation k (mV) 10.6 ± 0.7 9.3 ± 0.8 0.076 12
Inactivation V½ (mV) -80.6 ± 0.7 -86.7 ± 1.2 < 0.001 13
Inactivation k (mV) -4.8 ± 0.4 -7.4 ± 1.7 0.139 13
Peak current density at -10 mV (pA/pF) -14.8 ± 3.9 -8.0 ± 2.5 < 0.001 13
Persistent current density at -10 mV (pA/pF) -0.15 ± 0.05 -0.02 ± 0.07 0.13 12
Tp at -10 mV (ms) 2.1 ± 0.2 1.9 ± 0.2 < 0.01 13
τf at -10 mV (ms) 1.3 ± 0.1 1.3 ± 0.2 0.954 13
τs at -10 mV) (ms) 10.0 ± 2.3 6.9 ± 2.0 0.289 13
τr (ms) 6.0 ± 0.5 8.7 ± 0.7 < 0.05 10
B. HEK-Nav1.5 cells
Parameter Control ESL P value N
Vthres (mV) -55.0 ± 1.7 -54.0 ± 2.2 0.758 10
Vpeak (mV) -26.0 ± 2.2 -24.0 ± 4.3 0.591 10
Activation V½ (mV) -39.4 ± 1.3 -44.2 ± 1.8 < 0.05 10
Activation k (mV) 5.3 ± 1.3 3.8 ± 0.7 0.361 10
Inactivation V½ (mV) -78.2 ± 2.5 -88.3 ± 2.7 < 0.001 10
Inactivation k (mV) -6.9 ± 0.4 -9.8 ± 0.7 < 0.001 10
Peak current density at -10 mV (pA/pF) -154.4 ± 24.0 -33.1 ± 4.7 < 0.001 12
Persistent current density at -10 mV (pA/pF) -0.61 ± 0.15 -0.12 ± 0.05 < 0.01 12
Tp at -10 mV (ms) 1.4 ± 0.2 1.9 ± 0.2 < 0.001 14
τf at -10 mV (ms) 0.9 ± 0.1 1.2 ± 0.1 < 0.001 12
τs at -10 mV (ms) 6.6 ± 0.8 20.8 ± 8.5 0.128 12
τr (ms) 4.5 ± 0.4 7.1 ± 0.6 < 0.001 10

1ESL, eslicarbazepine acetate (300 µM); Vthres, threshold voltage for activation; Vpeak, voltage at which current was maximal; V½, half (in)activation voltage; k, slope factor for (in)activation; Tp, time to peak current; τf, fast time constant of inactivation; τs, slow time constant of inactivation; τr, time constant of recovery from inactivation. The holding potential was -120 mV. Results are mean ± SEM. Statistical comparisons were made with paired t-tests.